Related Experiment Video
Updated: Aug 21, 2026

Monitoring Protein-RNA Interaction Dynamics In Vivo at High Temporal Resolution Using χCRAC
Published on: May 9, 2020
Regulation of RARbeta1 expression in head and neck cancer cells by cell density-dependent chromatin remodeling
Emile M Youssef1, Jean-Pierre J Issa, Reuben Lotan
1Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. eyoussef@mdanderson.org
Abstract:
Retinoids have shown significant activities in cancer prevention and therapy. Many of their effects are mediated by nuclear retinoid receptors including retinoic acid receptors (RARs alpha, beta and gamma) and retinoid X receptors (RXRs alpha, beta and gamma). Human retinoic acid receptor beta (RARbeta) has three different isoforms: beta1, beta2 and beta4. The tumor suppressive characteristics of RARbeta2, its silencing by promoter hypermethylation, and its reexpression following demethylation have been reported. In contrast, RARbeta1, an embryonic isoform with restricted expression in adult tissues has been linked to carcinogenesis. However, factors regulating RARbeta1 expression have not yet been clarified. During studies on the head and neck squamous cell carcinoma cells, we found that the expression of RARbeta increased in cells grown to high density. Real-time reverse-transcriptase polymerase chain reaction revealed that the isoform increased in these cells was RARbeta1. Epigenetic modifications of this isoform were tested using combined bisulfite restriction analysis and chromatin immunoprecipitation assays. The UMSCC38 cell line showed significant RARbeta1 expression (p < 0.001), which was dependent on cell density and culture duration. The increased expression of RARbeta1 was not due to demethylation of its promoter. However, higher cell densities were associated with increased acetylation of histone 3 at lysine 9 in RARbeta1 but not in RARbeta2. These findings reveal that the expression of RARbeta1 is regulated by cell density through changes in histone acetylation.
Insights
Retinoid signaling impacts cancer. Researchers found that retinoic acid receptor beta 1 (RARbeta1) expression increases with cell density in head and neck cancer cells, regulated by histone acetylation.
Area of Science:
- Molecular biology
- Cancer research
- Epigenetics
Background:
- Retinoids are crucial in cancer therapy, acting via nuclear receptors like retinoic acid receptors (RARs).
- Human RARbeta has isoforms RARbeta1, RARbeta2, and RARbeta4, with RARbeta2 being tumor-suppressive and RARbeta1 linked to carcinogenesis.
- Factors regulating RARbeta1 expression remain unclear.
Purpose of the Study:
- To investigate the factors regulating the expression of the RARbeta1 isoform in head and neck squamous cell carcinoma.
- To explore the epigenetic mechanisms controlling RARbeta1 expression in response to cellular conditions.
Main Methods:
- Utilized real-time reverse-transcriptase polymerase chain reaction to quantify RARbeta isoform expression.
- Employed combined bisulfite restriction analysis and chromatin immunoprecipitation assays to assess epigenetic modifications.
- Cultured head and neck squamous cell carcinoma cells at varying densities and durations.
Main Results:
- RARbeta1 expression significantly increased in UMSCC38 cells with higher cell density and longer culture duration.
- This increase was not attributed to promoter demethylation.
- Higher cell densities correlated with increased histone 3 acetylation at lysine 9 specifically in RARbeta1, not RARbeta2.
Conclusions:
- Cell density is a key regulator of RARbeta1 expression in head and neck squamous cell carcinoma.
- Histone acetylation, specifically H3K9 acetylation, mediates the cell density-dependent regulation of RARbeta1.
- Understanding RARbeta1 regulation offers insights into retinoid signaling in cancer development.
Related Concept Videos
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the timing and level of...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Negative Regulator Molecules
Regulation of Nuclear Protein Sorting
RNA Polymerase II Accessory Proteins
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...
